Retina Health Connect
  • Saved
Risk Factors and Treatment Strategy for Retinal Vascular Occlusive Diseases - PubMed

Risk Factors and Treatment Strategy for Retinal Vascular Occlusive Diseases - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36362567/

Retinal occlusive diseases are common diseases that can lead to visual impairment. Retinal artery occlusion and retinal vein occlusion are included in the clinical entity, but they have quite different...


Conclusions: In this review, we summarize the current findings and advances in knowledge regarding retinal occlusive diseases, particularly focusing on recent studies, in order to provide an update for a better understanding of its pathogenesis.

  • Saved
A Linkage between Angiogenesis and Inflammation in Neovascular Age-Related Macular Degeneration - PubMed

A Linkage between Angiogenesis and Inflammation in Neovascular Age-Related Macular Degeneration - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36359849/

Age-related macular degeneration (AMD) is the leading cause of visual impairment in the aging population with a limited understanding of its pathogenesis and the number of patients are all the...


Relevance: Relevance: In this review, we connect angiogenesis and inflammatory regulators in the development of nAMD and discuss therapy challenges and hopes.



  • Saved
Six-month sustained delivery of anti-VEGF from in-situ forming hydrogel in the suprachoroidal space

Six-month sustained delivery of anti-VEGF from in-situ forming hydrogel in the suprachoroidal space

Source : https://www.sciencedirect.com/science/article/abs/pii/S0168365922007064?via=ihub

Anti-VEGF released for 6 months from in-situ forming hydrogel in the suprachoroidal space. * Bevacizumab and hyaluronic acid crosslinked with poly(ethylene glycol) diacrylate. * Hydrogel formulation covered a large area...

/>

Conclusions: Bev released from an in-situ forming hydrogel may enable long-acting treatments of AMD and other posterior ocular indications.


  • 3yr
    Key Points • Source: Journal of Controlled Release • Conclusion: ”We conclude that Bev [bevacizumab ] released from an in-situ forming hydrogel may enable long-acting treatments of AMD and other posterior ocular indications.” • The researchers Show More
  • Saved
Comparison of the Effect of Bromfenac versus Betamethasone Ophthalmic Solutions in Patients with Diabetic Macular Edema - PubMed

Comparison of the Effect of Bromfenac versus Betamethasone Ophthalmic Solutions in Patients with Diabetic Macular Edema - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36331099/

doi: 10.1080/02713683.2022.2140438. Online ahead of print. 1 Diabetes Center, Tokyo Women's Medical University Hospital, Tokyo, Japan. 2 Minami Diabetes Clinical Research Center, Fukuoka, Japan. 3 Kansai University of Welfare Sciences,...



Conclusions: BF did not affect IOP even after 12 weeks of administration, suggesting its effect in reducing CST in DME with good glycemic control.

  • Saved
Pachychoroid neovasculopathy can mimic wet type age-related macular degeneration - International Journal of Retina and Vitreous

Pachychoroid neovasculopathy can mimic wet type age-related macular degeneration - International Journal of Retina and Vitreous

Source : https://journalretinavitreous.biomedcentral.com/articles/10.1186/s40942-022-00429-6

Purpose to determine the percentage of patients with pachychoroid neovasculopathy (PNV) among patients who have been misdiagnosed and treated with wet age-related macular degeneration (AMD). Methods In this retrospective cross-sectional...


Conclusions: "This study revealed that about a one-fifth of wet AMD patients are actually pachychoroid neovasculopathy. These patients were younger and had thicker SFCT, and developed less subretinal scarring. Thus, the disorder must be considered as an important differential diagnosis of AMD-CNV."